Key facts
- This page summarizes Sam Eldessouky's Form 4 filing for Bausch & Lomb Corp (BLCO).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 09 May 2022, 18:44.
Sam Eldessouky - 05 May 2022 Form 4 Insider Report for Bausch & Lomb Corp (BLCO)
- Signature
- /s/ Debra E. Levin, attorney-in-fact
- Issuer symbol
- BLCO
- Transactions as of
- 05 May 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 09 May 2022, 18:44:50 UTC
- Previous filing
- 07 Mar 2022
- Next filing
- 27 Jul 2022
- SEC
- View on sec.gov
Key filing fact
Sam Eldessouky filed Form 4 for Bausch & Lomb Corp (BLCO) on 09 May 2022.
Change
- Previous filing in this sequence was filed on 07 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
BLCO
transaction
Common Shares, No Par Value
Award
- Transaction value
- $0
- Shares
- +125,000
- Change %
- Price
- $0.000000
- Shares after
- 125,000
- Date
- 05 May 2022
- Ownership
- Direct
- Footnotes
- F1
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
BLCO
transaction
Derivative
Non-Qualified Stock Options (right to purchase)
Award
- Transaction value
- $0
- Shares
- +494,505
- Change %
- Price
- $0.000000
- Shares after
- 494,505
- Date
- 05 May 2022
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 494,505
- Exercise price
- $18.00
- Footnotes
- F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. |
| F2 | Reflects the grant of stock options to purchase Common Shares under the Plan. |
| F3 | The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. |
| F4 | The stock options will expire on the tenth anniversary of the grant date. |